Is 0474.HK overvalued or undervalued?

0474.HK currently has a P/E ratio of 3.00. Relative to the sector average of 8.70, this suggests the stock may be undervalued. A higher P/E than peers means investors are paying more for each unit of earnings, often because they expect faster future growth. However, if that growth does not materialize, the stock can appear overvalued. A lower P/E may indicate weaker growth expectations or higher risk, but it can also signal a potential valuation discount.

How can I buy Aceso Life Science Group Limited stock?

Aceso Life Science Group Limited trades on HKSE. Investors in Latin America can buy it through international and regional brokerage and investment platforms. You simply need a valid government ID or passport to get started.

Can I buy fractional shares of 0474.HK?

Yes. Through fractional investing, you can invest exactly the amount you want, starting with as little as $1 or $5 USD (depending on what investment platform you use), and own a proportional piece of the company.

Does buying 0474.HK protect my money against local inflation?

Many investors in Latin America buy international stocks like 0474.HK to protect their purchasing power. Because 0474.HK is priced in foreign currency, your investment is tied to a hard currency. If your local currency devalues against the foreign currency, usually USD or Euro, the underlying value of your stock portfolio remains protected from local inflation.

Do I need a foreign bank account or a Visa to buy 0474.HK shares?

No. A common misconception is that you need a foreign bank account or a foreign visa to invest in international stocks. Today, modern investment platforms allow you to fund your account using local bank transfers or local payment methods right from your home country.

Is 0474.HK a suitable investment for my portfolio?

There is no universal answer, since fit depends on your situation, not just the stock. Think about three things: how well 0474.HK diversifies what you already own, whether you can stomach its price swings given your risk tolerance, and how long you plan to stay invested. As a rule, a single stock works best as one piece of a broader asset allocation and with a multi-year time horizon. This is general information, not personalized financial advice.

All stocks0474.HK

Aceso Life Science Group Limited

HK$0.14+HK$0.00+0.00%

HKSE / HKD

Market cap

HK$1.3B

P/E

3.0

EPS (TTM)

HK$0.00

Dividend yield

0.00%

Beta

-0.36

1Y return

—

Deposit US$200 and get US$50 for freeT&C apply. Your capital is at risk.Invest with

Compare, tap a companyup to 2 at once

Deposit US$200 and get US$50 for freeT&C apply. Your capital is at risk.Invest with

Financials

The numbers behind the company

Revenue vs net income

RevenueNet income

$40M2021

$40M2022

$1M2023

$25M2024

$8M2025

Financial health

Gross margin

Operating margin

ROE

ROA

Debt to equity2.60High
Current ratio5.52
Cash ratio2.30
Net margin528.1%
Free cash flow—

Valuation

Is it expensive right now

P/E vs the market

scale 0–50

0153050

0474.HK3.0
Industrials sector median8.7
S&P 50022.0

Trades about 65% below its sector, cheaper than its peers on earnings.

Ratios

PEG0.01
Price to book2.76
EPS (TTM)HK$0.00
Payout ratio0%
FCF yield2.87%

Range & risk

HK$0.06HK$0.16

Trading in the upper third of its 52-week band

Beta-0.36

Profile

What Aceso Life Science Group Limited actually does

Aceso Life Science Group Limited, an investment holding company, engages in the financial services, property leasing and development, and construction machinery businesses in Hong Kong and the United Kingdom. It operates through rental and sale of construction machinery and spare parts business; provision of repair and maintenance and transportation service business; money lending business; provision of asset management, securities brokerage and other financial service business; property leasing business; and property development business segments. The company leases and sells construction machinery, including crawler cranes, mobile cranes, aerial platforms, and foundation equipment, as well as spare parts; and sells construction materials. It also provides repair and maintenance services for construction machinery; transportation services, such as local container delivery, construction site delivery, and heavy machinery transport; mortgaged and personal loans; and money lending, asset management, commodities, futures, securities brokerage, and other financial services. In addition, the company retails men's and women's apparel; and provides group management, administration, and securities investment services. Further, the company involved in trading of futures and bioscience; and urban development businesses. The company was formerly known as Hao Tian Development Group Limited and changed its name to Aceso Life Science Group Limited in October 2020. Aceso Life Science Group Limited was founded in 1985 and is based in Wan Chai, Hong Kong.

CEO

Shen Hui

Employees

Headquarters

Hong Kong

Founded

2006-06-06

Company website

If you had invested a decade ago

Loading the full price history…

Run your own numbers

Past performance is not a forecast.

ETFs

Own it inside an ETF instead

Vanguard S&P 500

Vanguard Total Stock Market

Vanguard Total World Stock

Invesco QQQ

SPDR S&P 500

iShares Russell 2000

Community sentiment

Bullish—

Distribution

Bearish0%
Neutral0%
Bullish0%

Track it without buyingTrack it

no account needed

Save 0474.HK and get told when something moves.

Get updates

A clear, direct weekly summary.

Keep looking

Q&A

Questions people ask

0474.HK has a beta of -0.36, which indicates how sensitive it has historically been to movements in its broader market. A beta below 1 indicates lower relative volatility than the market. Beta is based on historical data and does not predict future performance.

Aceso Life Science Group Limited